Correction: Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Applying Clinical Trial Evidence for Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema to Clinical Practice

  • By

  • Sobha Sivaprasad

  • Michael W. Stewart

  • Charles C. Wykoff

  • David Eichenbaum

  • Jean-Francois Korobelnik

  • Paolo Lanzetta

  • Varun Chaudhary

  • Chui Ming Gemmy Cheung

  • Richard Gale

  • Marion R. Munk

  • Taiji Sakamoto

  • Andreas Stahl

  • Javier Zarranz-Ventura

  • Tien Yin Wong

  • Frank G. Holz

  • Anat Loewenstein

  • October 20, 2026

Share

Objective:

To notify readers that the original article has been corrected.

Approach:
  • Publication: The correction was published online on 7 August 2026.
  • Changes: Typos were corrected in the article text, references, funding statement, and competing interest section.
Key Findings:
  • The original article has undergone correction.
Interpretation:

The notice reports editorial corrections and does not describe changes to the article’s findings.

Sources:

Original Source(s)

Correction: Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice

  • by Sobha Sivaprasad, Michael W. Stewart, Charles C. Wykoff, David Eichenbaum, Jean-Francois Korobelnik, Paolo Lanzetta, Varun Chaudhary, Chui Ming Gemmy Cheung, Richard Gale, Marion R. Munk, Taiji Sakamoto, Andreas Stahl, Javier Zarranz-Ventura, Tien Yin Wong, Frank G. Holz, Anat Loewenstein

  • October 20, 2026

Related Content

Hidden eyelash mimics uveitis

Ultrasound biomicroscopy detected a foreign body concealed in the angle recess after inflammation subsided.

Large language models as internal consistency checkers for ophthalmic manuscripts

Comparison of Two AI Chatbots for Diagnosis and Providing Treatment Suggestions in Retinopathy of Prematurity: Retrospective Study